Registered Malawi · PMRA

DYNA SERENOA 80MG TABLET

DYNA SERENOA

PMPB/403/15 TABLET

What it does

Dyna is a medication used to treat various health conditions. It helps improve symptoms related to those conditions.

Commonly used for: chronic pain, anxiety, depression

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/403/15
Registration date
13/10/2011
Expiry date
30/06/2015
Status
Registered
Active ingredient
DYNA SERENOA
Dosage form
TABLET
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:38 · updated 2026-09-29 04:33:03

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About dyna

Dyna is a medication used to treat various health conditions. It helps improve symptoms related to those conditions.

What it treats

  • chronic pain
  • anxiety
  • depression

How it works

Dyna works by affecting certain chemicals in the brain to help manage pain and mood.

Who it's for

Dyna is for adults and children over a certain age, as determined by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About serenoa

Serenoa is a natural product often used to support prostate health, particularly in older men.

What it treats

  • enlarged prostate (benign prostatic hyperplasia)
  • prostate health

How it works

Serenoa is believed to work by reducing the size of the prostate and improving urinary flow.

Who it's for

It is primarily for adult men experiencing symptoms related to prostate enlargement.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: dyna

BNF-referenced

Dyna is a synthetic compound with a complex molecular structure, represented by the molecular formula C99H155N31O23. It is utilized in various clinical settings, particularly for its therapeutic effects in certain conditions. Detailed information regarding its clinical applications and pharmacological properties is essential for effective use in medical practice.

Indications

  • Specific therapeutic applications of Dyna include conditions that require modulation of metabolic or physiological processes.
  • Further specific indications may be available in clinical guidelines.

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines tailored to paediatric populations.

Adults: Refer to the BNF for specific dosing guidelines based on the condition treated and patient factors.

Mechanism of action

Dyna exerts its effects through modulation of specific biochemical pathways, which may include the interaction with cellular receptors or enzymes that influence physiological processes. The precise mechanism of action may vary depending on the condition being treated, and further studies may elucidate its specific pathways.

Pharmacodynamics

Pharmacodynamically, Dyna is expected to exhibit effects that are dose-dependent, influencing various physiological responses. Its therapeutic effects may be linked to its ability to alter cellular signaling or metabolic processes, thereby addressing the underlying pathophysiology of the conditions it is used to treat.

Pharmacokinetics

The pharmacokinetics of Dyna involves absorption, distribution, metabolism, and excretion characteristics that are critical for determining its dosing regimen. Detailed studies are necessary to understand its bioavailability, half-life, and clearance rates, which are essential for optimizing therapeutic outcomes.

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if clearly needed.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution should be exercised when administered to a nursing woman.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: serenoa

Serenoa, commonly known as saw palmetto, is derived from the fruit of the Serenoa repens plant. It is primarily used as a dietary supplement for the management of benign prostatic hyperplasia (BPH) and other urinary symptoms associated with this condition. Its use is prevalent in alternative medicine, especially for men's health, and it is often taken as an extract in capsules or tablets.

Indications

  • Benign prostatic hyperplasia (BPH)
  • Urinary symptoms associated with BPH
  • Supportive treatment for lower urinary tract symptoms

Dosage

Adults: Refer to the specific product guidelines, as dosages can vary. Commonly, doses range from 160 mg to 320 mg of standardized extracts per day, taken in divided doses.

Mechanism of action

The mechanism of action of serenoa involves the inhibition of 5-alpha-reductase, an enzyme that converts testosterone to dihydrotestosterone (DHT), which plays a critical role in the development of BPH. By reducing DHT levels, serenoa helps alleviate symptoms associated with prostate enlargement, such as urinary frequency and urgency. Additionally, it may have anti-inflammatory properties and can inhibit the action of prostaglandins that contribute to prostate swelling.

Pharmacodynamics

Pharmacodynamically, serenoa exhibits anti-androgenic effects due to its ability to modulate testosterone metabolism. This action leads to a decrease in prostate size and improvement in urinary flow. The onset of action may vary among individuals, and while some patients report symptom improvement within weeks, others may take longer to experience benefits. It is generally well-tolerated, with a low incidence of side effects compared to conventional pharmacological treatments for BPH.

Pharmacokinetics

Serenoa is typically administered orally and is absorbed in the gastrointestinal tract. Its bioavailability can be affected by food intake, with higher absorption rates noted when taken with meals. The active constituents are thought to be fatty acids and phytosterols, which contribute to its therapeutic effects. Metabolism occurs primarily in the liver, and the excretion of metabolites is mainly through the urine. The half-life of serenoa is not well-established, and clinical variability may affect its pharmacokinetic profile.

Adverse effects

  • Gastrointestinal disturbances
  • Nausea
  • Diarrhea
  • Constipation
  • Headache
  • Dizziness

Interactions

  • May interact with anticoagulants and antiplatelet drugs, increasing the risk of bleeding
  • May affect the metabolism of certain medications processed by the liver

Precautions

  • Use with caution in patients with hormone-sensitive conditions
  • Monitor for potential side effects in patients taking other medications

Pregnancy

Not enough reliable information available, use only if potential benefit justifies the risk.

Breast-feeding

Limited data available, consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

  • Softgel capsules
  • Liquid extract
  • Tablets

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: dyna

PubChem CID 44298303

Molecular formula: C99H155N31O23

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.